/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

PMV PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

PMV PHARMACEUTICALS INC share price today is $1.5965, up -1.25%. The stock opened at $1.595 against the previous close of $1.6, with an intraday high of $1.6 and low of $1.565.

PMV PHARMACEUTICALS INC Share Price Chart

style
pb-0

PMV PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

PMV PHARMACEUTICALS INC Share Price Performance

$1.5965 -0.0125(-1.25%) PMVP at 13 Mar 2026 02:48 PM Biotechnology
Lowest Today 1.565
Highest Today 1.6
Today’s Open 1.595
Prev. Close 1.6
52 Week High 1.88
52 Week Low 0.81
Day’s Range: Low 1.565 High 1.6
52-Week Range: Low 0.81 High 1.88
1 day return -
1 Week return -3.37
1 month return +43.18
3 month return +31.79
6 month return +36.95
1 year return +27.01
3 year return -71.54
5 year return -96.07
10 year return -

PMV PHARMACEUTICALS INC Institutional Holdings

Orbimed Advisors, LLC 11.23

BML Capital Management LLC 9.95

TANG CAPITAL MANAGEMENT LLC 8.99

ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 5.81

Sio Capital Management, LLC 4.95

Euclidean Capital LLC 4.94

Vanguard Group Inc 4.08

Acadian Asset Management LLC 3.88

Vanguard Total Stock Mkt Idx Inv 2.79

ArrowMark Small Cap Gro 2.34

Meridian Small Cap Growth Legacy 2.34

Stonepine Capital Management Llc 2.16

BlackRock Inc 2.08

Two Sigma Advisers, LLC 1.64

Two Sigma Investments LLC 1.33

Marshall Wace Asset Management Ltd 1.15

Jacobs Levy Equity Management, Inc. 0.99

Aldebaran Capital LLC 0.90

Geode Capital Management, LLC 0.81

Bridgeway Capital Management, LLC 0.81

Vanguard Institutional Extnd Mkt Idx Tr 0.77

Jane Street Group LLC 0.72

Northern Trust Corp 0.72

Walleye Trading Advisors, LLC 0.63

Bridgeway Ultra-Small Company 0.62

Fidelity Extended Market Index 0.41

iShares Micro-Cap ETF 0.22

Blackrock Extended Mkt Fund CF 0.19

Extended Equity Market Fund K 0.16

Goldman Sachs Absolute Ret Trckr Instl 0.15

Bridgeway Ultra-Small Company Market 0.14

Fidelity Total Market Index 0.13

Invesco Technology S&P US Sel Sec ETF 0.13

Nationwide Bailard Sm Cp Val M 0.12

Fidelity Series Total Market Index 0.11

Spartan Extended Market Index Pool F 0.10

Multi-Manager Small Cap Eq Strat Inst 0.10

Northern Trust Extended Eq Market Idx 0.09

NT Ext Equity Mkt Idx Fd - L 0.09

NT Ext Equity Mkt Idx Fd - NL 0.09

PMV PHARMACEUTICALS INC Market Status

Strong Buy: 4

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

PMV PHARMACEUTICALS INC Fundamentals

Market Cap 85.14 M

PB Ratio 0.7124

PE Ratio 0.0

Enterprise Value -43.18 M

Total Assets 116.56 M

Volume 134294

PMV PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-72549000 -72.5M, FY22:-73317000 -73.3M, FY21:-57846000 -57.8M, FY20:-34440000 -34.4M, FY19:-25352000 -25.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-32000 -0.0M, Q2/2025:-32000 -0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-372000 -0.4M

Quarterly Net worth Q3/2025:-21059000 -21.1M, Q2/2025:-21210000 -21.2M, Q1/2025:-17436000 -17.4M, Q3/2024:-19226000 -19.2M, Q2/2024:-1213000 -1.2M

About PMV PHARMACEUTICALS INC & investment objective

Company Information PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Organisation Biotechnology

Employees 47

Industry Biotechnology

CEO Dr. David H. Mack Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow